Treatment With Acthar

Acthar offers flexible dosing for your patients:

  • The gel formulation is designed to provide a prolonged release of medication after injection
  • Acthar is a self-administered, which gives patients the flexibility to take it at home or wherever it is best for them
  • Dosage and frequency of administration should be individualized according to the medical condition, disease severity, and initial response of the patient

Dosing options according to the label

Injection Subcutaneous or intramuscular
Dose 40-80 units
Schedule Every 1–3 days

SC Injection Training Video

Step-by-step instructions on how to inject Acthar subcutaneously.

Step-by-step instructions on how to inject Acthar subcutaneously.1:33

IM Injection Training Video

Step-by-step instructions on how to inject Acthar intramuscularly.

Step-by-step instructions on how to inject Acthar subcutaneously.1:31

To help your patients prepare to self-inject, share and watch the appropriate training video with them.

Patients can get injection training by a licensed nurse, available at no cost through the Acthar Hub. Learn more >

Acthar is indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy).

REQUEST A VISIT FROM AN ACTHAR SPECIALTY SALES CONSULTANT

If you have any questions about Acthar or just need more information, we'll arrange for an Acthar Specialty Sales Consultant to visit your practice. Learn more >

REVIEW ACTHAR CLINICAL EXPERIENCE

Read about the efficacy and safety of Acthar in the treatment of RA as shown in three separate patient datasets. Go >

IMPORTANT SAFETY INFORMATION

SEE More

Contraindications

  • Acthar should never be administered intravenously
  • Administration of live or live attenuated vaccines is contraindicated in patients receiving immunosuppressive doses of Acthar
  • Acthar is contraindicated where congenital infections are suspected in infants
  • Acthar is contraindicated in patients with scleroderma, osteoporosis, systemic fungal infections, ocular herpes simplex, recent surgery, history of or the presence of a peptic ulcer, congestive heart failure, uncontrolled hypertension, primary adrenocortical insufficiency, adrenocortical hyperfunction or sensitivity to proteins of porcine origins

INDICATIONS

SEE More

H.P. Acthar® Gel (repository corticotropin injection) is an adrenocorticotropic hormone (ACTH) analogue used for:

  • Treatment during an exacerbation or as maintenance therapy in selected cases of systemic dermatomyositis (polymyositis)
  • Treatment during an exacerbation or as maintenance therapy in selected cases of systemic lupus erythematosus
  • The treatment of symptomatic sarcoidosis
  • Adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy)